Centre Hospitalier Universite De Laval

Clinical research is centered on atrial fibrillation management in the context of left atrial appendage closure, with attention to post-procedural outcomes and thrombotic complications.

• Device thrombosis after LAAC
• Anticoagulation therapy
• Antiplatelet therapy

The sponsor’s trial activity reflects a focused interest in preventing thrombotic events associated with cardiac structural intervention and rhythm-related cardiovascular disease.